Neurological involvement in sarcoidosis is serious and often aggressive. Many patients respond to steroids, but some show a progressive course despite treatment with steroids and even more potent immunosuppressive drugs. We aimed to describe our experience in the treatment of refractory neurosarcoidosis with Infliximab; its effect on the course of the disease and side effects. We report a series of four patients with neurosarcoidosis refractory to treatment with steroids combined with various immunosuppressive drugs in whom Infliximab was used. A good response, with improvement or stabilization of the neurological condition was seen in all cases, without significant side effects. Infliximab is a chimeric monoclonal antibody that neutralises the biological activity of TNF-α, a cytokine thought to play an important role in the pathophysiology of sarcoidosis. Our experience using infliximab adds to growing evidence that it may fulfil a useful role in cases of refractory neurosarcoidosis.